microRNAs (miRNAs) are short non-coding RNAs that regulate gene expression by base
pairing with their target messenger RNAs. Dysregulation of miRNAs is involved in the …

ABSTRACT A large number of etiological factors and the complexity of breast cancers
present challenges for prevention and treatment. Recently, the emergence of microRNAs …

Objective Triple-negative breast cancer (TNBC) patients with truly chemosensitive disease
still represent a minority among all TNBC patients. The aim of the present study is to identify …

Mesoporous silica nanoparticles (MSNPs), 100 nm in size, incorporating a Cy5 fluorophore
within the silica framework, are synthesized and loaded with the anti‐cancer drug …

MicroRNAs are dysregulated in breast cancer. Heterogeneous Nuclear Ribonucleoprotein
A2/B1 (HNRNPA2/B1) is a reader of the N (6)-methyladenosine (m6A) mark in primary …

Although important advances in the management of breast cancer (BC) have been recently
accomplished, it still constitutes the leading cause of cancer death in women worldwide. BC …

MiRNAs are class of noncoding RNA important for gene expression regulation in many
plants, animals and viruses. MiRNA clusters contain a set of two or more miRNA encoding …

Breast cancer is a complex and heterogeneous disease. Signaling by estrogen receptor
(ER), progesterone receptor (PR), and/or human EGF-like receptor 2 (HER2) is a main driver …

Sunitinib is a multitargeting tyrosine kinase inhibitor used for metastatic renal cancer. There
are no biomarkers that can predict sunitinib response. Such markers are needed to avoid …

Osteosarcoma (OS) is an aggressive bone tumor primarily affecting children and
adolescents. The etiology of OS is not fully understood. Thus, there is a great need to obtain …